At a time when health care is rapidly evolving, dentistry is being reshaped by advances in technology, greater accountability ...

Research found just 4% of trials over the past decade allowed the inclusion of pregnant women.

NeuroRPM, a digital health company focused on Parkinson’s disease monitoring, today announced that its FDA-cleared wearable platform will be used for digital biomarker monitoring in Annovis Bio’s ANVS ...

Endpoints anchor clinical development. They define trial outcomes, determine regulatory approval and shape payer decision making. Traditional endpoints often rely on infrequent, clinic-based ...

Rentschler taps biopharma vet to lead ops. Rentschler Biopharma, the German CDMO with offices in Massachusetts and Stevenage, ...

ClinCapture President and CEO Scott Weidley today announced a major expansion of artificial intelligence capabilities within the company's Captivate® platform, embedding AI directly into the ...

ClinCapture announces AI-powered clinical trial build tech that automates study configuration, and advances intelligent ...

Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing a DMT for Parkinson’s.

Recent research provides robust evidence for the use of a digital visualization and decision support tool in colorectal (bowel) surgery. This is the first time that a digital decision support tool has ...

The Institute of Strategic Business Management and Public Administration (ISBMPA) Ghana has conferred Distinguished ...

Discover the impact of digital pathology on drug discovery and biomarker research this International Women’s Day with Dr ...